Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 84
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Anaesthesia ; 62(7): 741-3, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17567354

RESUMEN

We report an ischaemic penile glans following circumcision and a dorsal penile nerve block in a 9-year-old boy. Ischaemia of the glans penis is a rare complication associated independently with both circumcision and dorsal penile nerve blocks. There are a number of pathophysiological mechanisms of this ischaemia and its management is varied and not well recorded. We report the successful management of this complication using a caudal epidural block and also discuss technical aspects of penile nerve blocks.


Asunto(s)
Anestesia Caudal/métodos , Circuncisión Masculina/efectos adversos , Isquemia/etiología , Isquemia/terapia , Pene/irrigación sanguínea , Niño , Humanos , Masculino , Bloqueo Nervioso/efectos adversos
2.
J Endocrinol ; 165(2): 435-42, 2000 May.
Artículo en Inglés | MEDLINE | ID: mdl-10810307

RESUMEN

A panel of 11 rat monoclonal antibodies (mAbs) has been raised to ovine placental lactogen (PL). By competitive enzyme-linked immunoabsorbent assay (ELISA), confirmed by two-site ELISA, the antibodies were shown to recognize six antigenic determinants on the ovine PL molecule, two of which overlap. One antigenic determinant (designated 1) was shared by other members of the prolactin/growth hormone (GH)/PL family in ruminants, humans and rodents. The binding of (125)I-labelled ovine PL to crude receptor preparations from sheep liver (somatotrophic) or rabbit mammary gland (lactogenic) was inhibited by mAbs recognizing antigenic determinants 2-6. Both types of receptor preparation were affected similarly. In the local in vivo pigeon crop sac assay, mAbs directed against determinants 3 and 6 enhanced the biological activity of ovine PL.


Asunto(s)
Anticuerpos Monoclonales/aislamiento & purificación , Epítopos/análisis , Lactógeno Placentario/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Unión Competitiva , Ensayo de Inmunoadsorción Enzimática/métodos , Femenino , Conejos , Ratas , Ovinos , Bazo/inmunología
3.
J Reprod Fertil ; 116(1): 25-33, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10505053

RESUMEN

Interactive effects of light and temperature on aspects of seasonality were studied in female British Saanen dairy goats. Four groups of adult non-pregnant non-lactating goats (n = 5) were housed under the following conditions: controls (July-June): natural photoperiod and temperature; group 1 (July-December): long days (16 h light: 8 h dark) and natural temperature; group 2 (July-December): long days and average summer temperature (17.6 degrees C); group 3 (December-June): short days (8 h light: 16 h dark) and winter temperature (8.4 degrees C). Plasma prolactin and progesterone were measured once a week, circadian changes in prolactin and melatonin were determined in December and May, and coat development was assessed. Seasonal variation in prolactin was influenced by manipulation of both daylength and temperature. In group 1, prolactin concentrations decreased as the environmental temperature decreased, despite maintenance of long days. When light and temperature were maintained under summer (group 2) and winter (group 3) conditions, prolactin remained relatively constant, although at different high and low set points, respectively, but with indications of a seasonal rhythm. An asymptotic relationship between prolactin and temperature was maintained under all daylengths. The circadian pattern of melatonin was related to daylength and was not influenced significantly by temperature. Onset of oestrus was unaltered. In group 3 (maintained winter solstice light and temperature), anoestrus was delayed (P < 0.05) from a median control date of 17 March to a median date of 28 April. Winter coat development was delayed in group 1; group 2 showed premature moulting of the winter coat; and in group 3, development of the summer coat was delayed. The results imply that temperature modifies the influence of daylength on prolactin secretion and hair follicle growth by mechanisms that do not involve melatonin.


Asunto(s)
Estro/fisiología , Cabras/fisiología , Folículo Piloso/crecimiento & desarrollo , Calor , Luz , Estaciones del Año , Análisis de Varianza , Animales , Ritmo Circadiano , Estro/sangre , Femenino , Cabras/sangre , Melatonina/sangre , Progesterona/sangre , Prolactina/sangre , Estadísticas no Paramétricas
4.
J Dairy Res ; 66(1): 35-44, 1999 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10191471

RESUMEN

The mammary gland is an example of a tissue of epidermal origin that depends for the development of its characteristic morphology on underlying mesenchymal cells. The interaction between mesenchyme and epithelium appears to be mediated by polypeptide growth factors. In situ hybridization has been used to study, in the mammary gland of female sheep fetuses, the distribution of mRNA for the mammary mitogens, insulin-like growth factor (IGF)-I and IGF-II, and the IGF-I receptor, from 10 to 20 weeks of intrauterine life (term is approximately 22 weeks). At 10 weeks, secondary ducts had formed from the primary duct. By week 20, the gland had increased in volume and complexity, showing primitive lobules embedded in intralobular connective tissue disposed around main ducts. IGF-I and IGF-II mRNA were expressed in cells of the intralobular connective tissue underlying the epithelium, while the IGF-I receptor was expressed in epithelium. Quantitation by absorbance measurements showed that mRNA expression increased with pregnancy stage for IGF-I and IGF-II, but not significantly for the IGF-I receptor, and that IGF-II was more highly expressed than IGF-I. A role for the IGF system in mediating mesenchymal epithelial interactions in mammary development is indicated.


Asunto(s)
Expresión Génica , Factor II del Crecimiento Similar a la Insulina/genética , Factor I del Crecimiento Similar a la Insulina/genética , Glándulas Mamarias Animales/embriología , Receptor IGF Tipo 1/genética , Ovinos/embriología , Animales , Tejido Conectivo/química , Tejido Conectivo/embriología , Epitelio/química , Epitelio/embriología , Femenino , Edad Gestacional , Hibridación in Situ , Glándulas Mamarias Animales/química , Sondas de Oligonucleótidos , Embarazo , ARN Mensajero/análisis
5.
J Endocrinol ; 156(2): 283-90, 1998 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9518874

RESUMEN

Amphiregulin is a heparin-binding member of the epidermal growth factor (EGF) family, which we have recently shown to be expressed in sheep mammary gland. Uniquely among known EGF-like growth factors, its mitogenic activity is inhibited by soluble heparin, but heparin-like molecules on the cell surface and/or in extracellular matrix appear to be necessary for amphiregulin to exert its biological effect. In primary cultures of sheep mammary alveolar epithelial cells, heparin (1-20 mg/l) inhibited DNA synthesis in a dose-dependent manner. The extent of the inhibition was influenced by physiological state, being greater (P < 0.05) in mammary cell cultures derived from 5- to 10-week pregnant sheep (63.1 +/- 8.2%, mean +/- S.E.M., n = 8) than in cultures derived from sheep which were non-pregnant (35.8 +/- 8.3% inhibition, n = 6) or late, 20-week, pregnant (39.8 +/- 5.6%, n = 6). Both EGF and transforming growth factor-alpha (TGF-alpha) significantly (P < 0.001) increased DNA synthesis in the presence of heparin. The effect of TGF-alpha was dose-related, wholly reversing the inhibitory effect of heparin in cell cultures from non-pregnant and 20-week pregnant sheep. DNA synthesis was stimulated by amphiregulin and TGF-alpha increased the maximum response. The heparin antagonist, hexadimethrine, inhibited DNA synthesis, but, in the presence of amphiregulin, approximately equivalent concentrations of heparin overcame this inhibitory effect. In the presence of heparin, TGF-alpha showed synergistic interactions with insulin or IGF-I. The results indicate interactive effects of EGF and IGF growth factor families in sheep mammary growth.


Asunto(s)
ADN/biosíntesis , Factor de Crecimiento Epidérmico/farmacología , Heparina/farmacología , Péptidos y Proteínas de Señalización Intercelular , Glándulas Mamarias Animales/metabolismo , Preñez/metabolismo , Ovinos/metabolismo , Anfirregulina , Análisis de Varianza , Animales , Antineoplásicos/farmacología , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Femenino , Edad Gestacional , Glicoproteínas/farmacología , Sustancias de Crecimiento/farmacología , Bromuro de Hexadimetrina/farmacología , Insulina/farmacología , Factor I del Crecimiento Similar a la Insulina/farmacología , Glándulas Mamarias Animales/efectos de los fármacos , Microsomas/metabolismo , Embarazo , Factor de Crecimiento Transformador alfa/farmacología
6.
Mol Cell Endocrinol ; 126(1): 41-8, 1997 Jan 03.
Artículo en Inglés | MEDLINE | ID: mdl-9027362

RESUMEN

The reverse transcription-polymerase chain reaction (RT-PCR) was used to amplify, from sheep mammary gland total RNA, a 280 bp sequence of amphiregulin cDNA. Cloned and sequenced, it corresponded to the 78 amino acids of the major secreted form of amphiregulin, showing 81, 70 and 69% identity with human, rat and mouse amphiregulin, respectively. Expression of amphiregulin was detected by RT-PCR in the mammary gland at several developmental stages (fetal, lamb, early and late pregnant and lactating ewes) and in isolated myoepithelial cells. By Western blotting with an antiserum to human amphiregulin, two molecular weight forms, 27 and 51 kDa were detected in sheep mammary gland microsomal preparations, in a mammary gland extract after heparin affinity chromatography and in a medium conditioned by mammary epithelial cells. By immunocytochemistry, amphiregulin was detected in the cytoplasm and nuclei of luminal epithelial cells, myoepithelial cells and in intralobular stroma. An autocrine/paracrine role in sheep mammary growth is indicated.


Asunto(s)
Expresión Génica , Glicoproteínas/genética , Sustancias de Crecimiento/genética , Péptidos y Proteínas de Señalización Intercelular , Glándulas Mamarias Animales/metabolismo , Secuencia de Aminoácidos , Anfirregulina , Animales , Secuencia de Bases , Western Blotting , Clonación Molecular , ADN Complementario/química , Familia de Proteínas EGF , Femenino , Glicoproteínas/análisis , Glicoproteínas/química , Sustancias de Crecimiento/análisis , Sustancias de Crecimiento/química , Humanos , Inmunohistoquímica , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Embarazo , ADN Polimerasa Dirigida por ARN , Análisis de Secuencia de ADN , Ovinos
8.
J Dairy Sci ; 79(6): 1085-96, 1996 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8827474

RESUMEN

Selective breeding and improved management have had major effects in increasing peak milk yields but relatively little effect on lactation persistency. In ruminants, cell loss appears to be largely responsible for the decline in milk yield. Little is known about the longevity of individual cells, but, in lactating dairy cows, few epithelial cells are in the S phase (DNA synthesis) of the cell cycle. The IGF and epidermal growth factor families are direct mitogens, stimulating DNA synthesis in cultures of ruminant mammary epithelial cells. Receptors that mediate the effects of these growth factors, the type 1 IGF receptor and the epidermal growth factor receptor, respectively, are present at similar levels in membranes prepared from the mammary glands of nonpregnant and pregnant sheep. Binding capacity falls by parturition and remains low during lactation. These findings suggest that the drive to mammary development in pregnancy comes from control of growth factors, and, in the case of IGF, modulating binding proteins, a control exerted by hormones, which, in general, are not themselves mitogens. A paracrine or autocrine mode of action and, therefore, local growth factor synthesis, are more likely to be important than systemic concentrations of growth factor. Stimulatory growth factors produced locally by the mammary gland include IGF-I, IGF-II, transforming growth factor-alpha, and amphiregulin. More information is needed on the control of stimulatory and inhibitory growth factors and on how growth factors control the cell cycle. Knowledge of these processes could result in strategies to improve lactation persistency by increasing secretory cell renewal or reducing cell loss during lactation.


Asunto(s)
División Celular , Factor de Crecimiento Epidérmico/fisiología , Factor II del Crecimiento Similar a la Insulina/fisiología , Factor I del Crecimiento Similar a la Insulina/fisiología , Glándulas Mamarias Animales/citología , Rumiantes , Animales , Receptores ErbB/fisiología , Estrógenos , Femenino , Sustancias de Crecimiento/fisiología , Factor I del Crecimiento Similar a la Insulina/farmacología , Factor II del Crecimiento Similar a la Insulina/farmacología , Embarazo , Prolactina
9.
J Steroid Biochem Mol Biol ; 58(1): 117-21, 1996 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8809193

RESUMEN

A primary culture system of virgin rat mammary epithelial cells, grown in a serum-free medium, was developed as a means of assaying the efficacy of compounds with known anti-progestational properties. Cells were grown in 24-well plates on hydrated collagen gels and could be cultured for at least seven days. Experiments were routinely stopped three days after overnight attachment of cells using fibronectin (4 micrograms/ml). DNA synthesis, measured by thymidine incorporation, was significantly increased by the addition of ovine prolactin (43 nM; P < 0.01) or progesterone (0.15 microM; P < 0.05) or both (P < 0.01) to the basal medium. When added to medium containing progesterone plus prolactin (complete medium), RU486 (mifepristone) and ZK98734 (lilopristone) significantly depressed DNA synthesis in a dose-dependent manner using doses ranging from 0.015 microM to 15 microM. Maximum inhibition was achieved at 15 microM for both compounds. DNA synthesis was 24.5 +/- 2.6% (mean +/- SEM, n = 4) and 32.0 +/- 2.2% (n = 3) of that in complete medium for RU486 and ZK98734, respectively (both P < 0.001). There was no inhibitory effect of either compound in basal medium or basal medium plus prolactin, indicating the absence of toxicity and that the inhibitory effect is specific for a progesterone-mediated process.


Asunto(s)
Evaluación Preclínica de Medicamentos/métodos , Antagonistas de Hormonas/farmacología , Glándulas Mamarias Animales/efectos de los fármacos , Progesterona/farmacología , Animales , Técnicas de Cultivo de Célula/métodos , Células Cultivadas , Colágeno , Medios de Cultivo , ADN/biosíntesis , Células Epiteliales , Epitelio/efectos de los fármacos , Estrenos/farmacología , Femenino , Geles , Glándulas Mamarias Animales/citología , Mifepristona/farmacología , Prolactina , Ratas , Ratas Wistar , Ovinos
10.
J Endocrinol ; 146(3): 411-20, 1995 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7595136

RESUMEN

125I-Labelled ovine prolactin was infused for 15 min into a pudic artery supplying one mammary gland of lactating goats (n = 17). Between 0 and 4.25 h significantly more total (P < 0.01) and trichloroacetic acid (TCA)-precipitable (P < 0.001) radioactivity appeared in the milk of the infused compared with the non-infused gland. Gel chromatography and antibody precipitation indicated the presence of undegraded 125I-labelled prolactin in milk whey. Maximum transfer occurred 60-80 min after the end of infusion suggesting passage via a transcellular route. High plasma prolactin concentrations, resulting from infusion of cold prolactin with labelled prolactin in late lactation or from seasonally elevated prolactin at peak lactation, reduced the specific activity of infused prolactin and depressed the difference in secretion of 125I-labelled prolactin into milk of infused and non-infused glands. This suggests the operation of a competitive and saturable mechanism. Together with the increase in the milk to blood ratio of prolactin in goats given long-term (3 week) bromocriptine treatment, the results suggest that the goat mammary gland has a high avidity for prolactin especially when circulating prolactin is low. There was also evidence from TCA precipitation that prolactin may be protected from degradation in these circumstances. These mechanisms may contribute to the resistance of ruminant lactation to reduction in plasma prolactin and protect lactation from seasonal prolactin fluctuations.


Asunto(s)
Cabras/metabolismo , Lactancia , Leche/metabolismo , Prolactina/metabolismo , Animales , Bromocriptina/farmacología , Cromatografía de Afinidad , Cromatografía en Gel , Femenino , Cabras/sangre , Antagonistas de Hormonas/farmacología , Prolactina/sangre , Prolactina/farmacocinética
11.
Nat Genet ; 10(1): 28-34, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7647785

RESUMEN

A reduction of high density lipoprotein cholesterol (HDC) is recognized as an important risk factor for coronary artery disease (CAD). We now show in approximately 1 in 20 males with proven atherosclerosis that an Asn291Ser mutation in the human lipoprotein lipase (LPL) gene is associated with significantly reduced HDL levels (P = 0.001) and results in a significant decrease in LPL catalytic activity (P < 0.0009). The relative frequency of this mutation increases in those patients with lower HDL cholesterol levels. In vitro mutagenesis and expression studies confirm that this change is associated with a significant reduction in LPL activity. Our data support the relationship between LPL activity and HDL-C levels, and suggest that a specific LPL mutation may be a factor in the development of atherosclerosis.


Asunto(s)
Arteriosclerosis/etiología , HDL-Colesterol/metabolismo , Lipoproteína Lipasa/genética , Mutación , Adulto , Anciano , Alelos , Animales , Arteriosclerosis/genética , Arteriosclerosis/metabolismo , Secuencia de Bases , Línea Celular , Colesterol/metabolismo , Enfermedad Coronaria/etiología , Frecuencia de los Genes , Humanos , Lipoproteína Lipasa/fisiología , Lipoproteínas LDL/metabolismo , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Factores de Riesgo , Transfección , Triglicéridos/metabolismo
12.
J Endocrinol ; 144(1): 165-71, 1995 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-7891019

RESUMEN

Microsome factions prepared from the mammary glands of non-pregnant, pregnant and lactating sheep have been used to study binding of 125I-labelled transforming growth factor-alpha (TGF-alpha). Binding was dependent on microsomal protein concentration, time and temperature. It showed the characteristics of an epidermal growth factor (EGF) receptor, being displaced by TGF-alpha and EGF, but not by insulin or IGF-I. The non-linear curve fitting program LIGAND was used to determine affinity and number of binding sites. A single class of high-affinity binding sites was found. The apparent dissociation constant (Kd) was similar in all physiological states (2.43 +/- 0.27 mol/l x 10(-10), n = 23). Numbers of binding sites were lower in late-pregnant (20 weeks) and lactating sheep (14.07 +/- 2.45 fmol/mg protein, n = 10) than in non-pregnant, 10- or 15-week pregnant sheep (43.04 +/- 5.93 fmol/mg protein, n = 13). DNA synthesis by mammary alveolar epithelial cells cultured on collagen gels was increased twofold by TGF-alpha (maximum response at 10 micrograms/l; 1.8 nmol/l) but not by EGF. Cells derived from 15- to 20-week pregnant sheep responded significantly to TGF-alpha on day 3 of culture, but the response was delayed to day 4-5 of culture in cells from other physiological states. Dose-response was not significantly affected. TGF-alpha and IGF-I produced an additive effect on DNA synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
ADN/biosíntesis , Receptores ErbB/metabolismo , Glándulas Mamarias Animales/metabolismo , Ovinos/metabolismo , Factor de Crecimiento Transformador alfa/metabolismo , Animales , Sitios de Unión , Unión Competitiva , Células Cultivadas , Epitelio/metabolismo , Estradiol/farmacología , Femenino , Factor I del Crecimiento Similar a la Insulina/farmacología , Lactancia/metabolismo , Glándulas Mamarias Animales/efectos de los fármacos , Microsomas/efectos de los fármacos , Microsomas/metabolismo , Embarazo , Unión Proteica , Factores de Tiempo , Factor de Crecimiento Transformador alfa/farmacología
13.
J Dairy Res ; 61(1): 21-34, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8188944

RESUMEN

The whey proteins alpha-lactalbumin and beta-lactoglobulin have been investigated as potential markers of mammary development in sows by measuring their concentrations in plasma. The whey proteins were isolated from porcine milk by gel filtration, ion-exchange and hydrophobic interaction chromatography, characterized by several criteria and used to raise antibodies. Specific radioimmunoassays were set up for porcine alpha-lactalbumin and beta-lactoglobulin and validated for use in porcine blood and milk. Plasma levels of the whey proteins were measured in sows that were pregnant, suckling litters post partum, weaned abruptly at birth or were pregnant but mastectomized. Both whey proteins showed similar patterns in plasma post partum, falling from a maximum 1 d after parturition to values < 0.02% those in milk by day 4-5 post partum in suckling sows and showing a transient peak associated with early involution before declining to very low concentrations in non-suckling sows. alpha-Lactalbumin was first detected in the last week prepartum, rising markedly in the 3 d before parturition, correlated with rising prolactin (r = 0.986) and falling progesterone (r = -0.998). beta-Lactoglobulin rose much earlier from 5 weeks prepartum, at the time when lobulo-alveolar mammary development is occurring, and correlated (r = 0.929) with oestradiol-17 beta. In mastectomized sows, concentrations of whey proteins in plasma were reduced by 90% or more when compared with intact animals, though following a similar pattern. This study shows that whey protein concentrations in plasma vary with physiological state and reflect aspects of the development of the mammary gland. The very different profiles for alpha-lactalbumin and beta-lactoglobulin prepartum indicate that they are differently controlled.


Asunto(s)
Glándulas Mamarias Animales/fisiología , Proteínas de la Leche/sangre , Porcinos/sangre , Animales , Estradiol/sangre , Femenino , Trabajo de Parto/fisiología , Lactalbúmina/aislamiento & purificación , Lactalbúmina/metabolismo , Lactancia/fisiología , Lactoglobulinas/aislamiento & purificación , Lactoglobulinas/metabolismo , Mastectomía , Leche/química , Embarazo , Progesterona/sangre , Prolactina/sangre , Porcinos/fisiología , Proteína de Suero de Leche
14.
J Dairy Res ; 61(1): 35-45, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8188945

RESUMEN

Mammary tissue from pigs on days 60, 80, 90, 100 and 100+ (days 106-111) of pregnancy has been cultured in vitro as explants. The total accumulation in tissue and culture medium of the whey proteins alpha-lactalbumin and beta-lactoglobulin has been measured using specific radioimmunoassays. The control, uncultured tissue showed progressive morphological development from sparse, non-secretory epithelial tissue on day 60 to full lobulo-alveolar development with some accumulated secretion from day 100. In uncultured explants beta-lactoglobulin could be detected consistently from day 90 (13 +/- 12 ng/micrograms DNA, n = 4) and alpha-lactalbumin from day 100 (1.3 +/- 0.5 ng/micrograms DNA, n = 11). At all stages of pregnancy, both whey proteins increased markedly during the period of culture (up to 7 d). Stimulation of alpha-lactalbumin appeared to be primarily under prolactin control. Prolactin increased alpha-lactalbumin accumulation to a similar extent alone, or in the presence of insulin and/or corticosterone. The response to prolactin was dose-dependent over the range 0.4-20 nM (10-500 ng/ml). Porcine prolactin was more potent than ovine prolactin. There was no effect of porcine growth hormone and no synergism detected between prolactin and tri-iodothyronine. By contrast, no specific hormonal requirements were established for accumulation of beta-lactoglobulin, which appeared to increase in vitro if tissue remained viable in various combinations of insulin, corticosterone and prolactin. It was not stimulated by growth hormone. There was some indication of a prolactin-sensitive component in longer term cultures after day 4.


Asunto(s)
Lactalbúmina/biosíntesis , Lactoglobulinas/biosíntesis , Glándulas Mamarias Animales/metabolismo , Prolactina/farmacología , Porcinos/metabolismo , Animales , Corticosterona/farmacología , Medios de Cultivo , Técnicas de Cultivo , Femenino , Hormona del Crecimiento/farmacología , Insulina/farmacología , Glándulas Mamarias Animales/efectos de los fármacos , Embarazo , Factores de Tiempo
15.
Exp Clin Endocrinol ; 102(3): 244-51, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7995346

RESUMEN

Removal of the pituitary from pregnant rats provided early evidence that the placenta was the source of prolactin-like bioactivity. After mid-pregnancy the placenta was able to support progesterone production by the corpus luteum (luteotrophic activity) and continued development of the mammary gland (mammotrophic activity). Three groups of mammals, the rodents, the ruminant artiodactyls and the primates are now known to produce from fetal placenta a remarkable variety of proteins which are related in structure to pituitary prolactin and growth hormone. Prolactin and growth hormone are themselves structurally related and are thought to have arisen from a common ancestral gene by gene duplication and evolutionary divergence. The receptors with which they interact also form a family of homologous proteins. Surprisingly the placental lactogens appear to have arisen more than once in evolution since in primates they are structurally closely related to growth hormone, while in rodents and ruminants they have closer similarity to prolactin. There is suggestive evidence that there may be specific receptors for placental lactogens in some fetal and maternal tissues. In humans a five-gene cluster on chromosome 17 contains two growth hormone (GH) and three placental lactogen (PL) genes. Two human PL genes encode identical proteins that are expressed in the placenta. One of the human GH genes is also placentally expressed. In mice, chromosome 13 carries the genes for mouse prolactin, for placental lactogen-I and -II (PL-I and PL-II) and for two other prolactin-related proteins, the proliferins. Rats also express PL-I and PL-II, together with at least three other placental prolactin-like proteins different from proliferins.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Hormona del Crecimiento/fisiología , Hormonas Placentarias/fisiología , Prolactina/fisiología , Animales , Hormona del Crecimiento/química , Hormona del Crecimiento/genética , Humanos , Ratones , Familia de Multigenes , Hormonas Placentarias/química , Hormonas Placentarias/genética , Prolactina/química , Prolactina/genética , Ratas , Receptores de Péptidos/fisiología , Rumiantes , Especificidad de la Especie , Relación Estructura-Actividad
16.
J Dairy Res ; 60(3): 307-17, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-7690787

RESUMEN

British Saanen dairy goats (n = 10) were treated with bromocriptine or vehicle from day 147 of pregnancy to day 4 post partum, a treatment duration of 8.8 +/- 1.7 d (mean +/- SEM). The periparturient prolactin surge was abolished by this treatment, but there were no significant effects on plasma growth hormone or insulin concentrations. Lactogenesis was delayed in the bromocriptine-treated goats, milk yields being significantly depressed (P < 0.01) for the first week of lactation. Yields had recovered to control values by day 10 when prolactin concentrations were still significantly depressed. Mammary gland biopsies were taken on day 4 post partum from five animals in each group. Using this tissue, no significant differences could be shown in mammary morphology or DNA synthesis, but the RNA:DNA ratio was significantly reduced (P < 0.05). After week 1, there were no significant differences between bromocriptine-treated and control goats in milk yield, milk composition, udder volume, time of peak yield or persistence. The goats given short-term bromocriptine treatment at parturition showed prolonged effects on prolactin secretion, their seasonal prolactin rise being severely blunted (P < 0.001). A normal lactation is therefore not prevented in goats by a delay in lactogenesis, suppression of prolactin at parturition or the resulting prolonged depression of circulating prolactin. Goats in established lactation given bromocriptine for 8 d showed, by contrast, a rapid recovery of plasma prolactin concentrations within 5 d post treatment. Milk yield declined significantly (P < 0.03) compared with pretreatment values during and for 1 week after bromocriptine but then began to recover, with no significant change in vehicle-treated goats.


Asunto(s)
Bromocriptina/farmacología , Cabras/fisiología , Lactancia/efectos de los fármacos , Preñez/efectos de los fármacos , Prolactina/biosíntesis , Animales , ADN/biosíntesis , Femenino , Hormona del Crecimiento/sangre , Insulina/sangre , Glándulas Mamarias Animales/efectos de los fármacos , Glándulas Mamarias Animales/metabolismo , Leche/química , Leche/efectos de los fármacos , Leche/metabolismo , Embarazo , Preñez/metabolismo , ARN/biosíntesis , Radioinmunoensayo
17.
J Endocrinol ; 136(2): 297-304, 1993 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8459195

RESUMEN

Sucrose density centrifugation was used to prepare a partially purified membrane fraction from the mammary glands of non-pregnant, pregnant and lactating sheep. The binding of 125I-labelled insulin-like growth factor-I (IGF-I) was dependent on membrane protein concentration, pH, time and temperature. The binding showed the characteristics of a type-1 IGF receptor, being displaced by IGF-I (median effective dose (ED50) 0.55 nmol/l), less effectively by IGF-II (ED50 8.8 nmol/l) and least effectively by insulin. Glucagon, ovine prolactin and ovine placental lactogen could not displace binding. A molecular weight of 135,000 was determined by affinity cross-linking using disuccinimidyl suberate; this was consistent with the reported size of the type-1 receptor alpha-subunit. Scatchard analysis was used to determine binding affinity and numbers of IGF-I-binding sites. A single class of high-affinity binding sites was found in all physiological states. In non-pregnant sheep and sheep at days 40, 75 and 110-120 of pregnancy and at term, the binding affinity was similar (apparent dissociation constant (Kd) 2.73 +/- 0.31 nmol/l, n = 22). In lactating sheep (weeks 1, 4 and 10), the binding affinity was significantly (P = 0.02) higher (Kd 0.77 +/- 0.06 nmol/l n = 9). Binding capacity was similar in non-pregnant and pregnant sheep (1005 +/- 113 fmol/mg, n = 19), but fell by parturition and remained low in lactation (570 +/- 52 fmol/mg membrane protein, n = 12). The results suggest that the mammary growth of pregnancy is not regulated at the level of the type-1 IGF receptor.


Asunto(s)
Factor I del Crecimiento Similar a la Insulina/metabolismo , Lactancia/metabolismo , Glándulas Mamarias Animales/metabolismo , Preñez/metabolismo , Receptor IGF Tipo 1/metabolismo , Ovinos/metabolismo , Animales , Sitios de Unión , Femenino , Microsomas/metabolismo , Peso Molecular , Embarazo
18.
J Dairy Res ; 59(4): 491-8, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1280656

RESUMEN

Cells were obtained from the mammary glands of sheep and cows by collagenase-hyaluronidase digestion. Characterization of cells as epithelial was by reaction with a monoclonal antibody to cytokeratin. A subpopulation of spindle-shaped or stellate cells reacted with a monoclonal antibody to desmin and may be related to myoepithelial cells. The development is described of a simple serum-free culture system for these cells on gels of rat tail (type 1) collagen. A commercial medium (M199) was used, buffered with Hepes and with bovine serum albumin as the sole protein supplement, plus fibronectin for the first 18 h only as an attachment factor. The cell cultures showed stimulated DNA synthesis in response to mitogens on attached gels and also responded as floating cultures to lactogenic hormones with production of alpha-lactalbumin.


Asunto(s)
Bovinos/metabolismo , Glándulas Mamarias Animales/metabolismo , Ovinos/metabolismo , Animales , Anticuerpos Monoclonales , Adhesión Celular , División Celular , Células Cultivadas , Medios de Cultivo , ADN/biosíntesis , Desmina/análisis , Células Epiteliales , Epitelio/metabolismo , Femenino , Sangre Fetal , Inmunohistoquímica , Queratinas/análisis , Cinética , Lactalbúmina/metabolismo , Glándulas Mamarias Animales/citología
19.
J Pineal Res ; 13(1): 6-12, 1992 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-1331395

RESUMEN

The recent development of a specific 2-[125I]-iodo-melatonin ligand has led to the identification of 125I-melatonin binding sites in the brains of numerous mammalian species. The present study reports the localization of 125I-melatonin binding sites in the brain of the dairy goat. Six previously untreated female goats, aged 5-7 years, were culled under natural light between 0900 and 1100. Brains and pituitaries were immediately dissected out and frozen on dry ice. Both transverse and sagittal sections of frozen brain were cut 20 microns thick and thaw-mounted onto gelatin-coated slides. Three consecutive sections were cut at intervals throughout the brain, mounted onto three slides, labeled A, B, and C, and thusly treated: (A) incubated for 2 hr at room temperature in a 50 pM solution of 125I-melatonin; (B) incubated for 2 hr at room temperature in a 50 pM solution of 125I-melatonin plus 1 microM cold melatonin; (C) fixed in Clarke's fluid and stained with toluidine blue. After incubation, A (specific) and B (nonspecific) slides were washed three times in ice-cold Tris-HCl buffer (pH 7.7), air-dried, exposed to an X-ray film for 2 weeks at -20 degrees C, and then fixed and stained. Specific 125I-melatonin binding sites were found in the pars tuberalis (PT), the area of the suprachiasmatic nucleus (SCN), preoptic area (POA), fornix/mediolateral septal areas, hippocampus, and the cerebral cortex. 125I-melatonin did not bind in the hindbrain, midbrain, neurohypophysis, pars intermedia or pars distalis of the adenohypophysis, or the pineal.


Asunto(s)
Encéfalo/metabolismo , Cabras/metabolismo , Melatonina/metabolismo , Receptores de Neurotransmisores/metabolismo , Animales , Autorradiografía , Unión Competitiva , Femenino , Hipófisis/metabolismo , Ensayo de Unión Radioligante , Receptores de Melatonina
20.
J Reprod Fertil ; 95(2): 629-37, 1992 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-1518018

RESUMEN

Goat kids born in spring attain sexual maturity during the first autumn after birth in temperate regions, at about 30 weeks of age. This study observed sexual development in autumn-born kids and the influence of late-summer, prenatal light treatment on onset of puberty. The breeding season of 14 female British Saanen dairy goats was artificially advanced by 4 months, using a treatment of long days during the winter followed by melatonin treatment in spring. Five goats were treated with a photoperiod of 20 h light:4 h dark (lights on 04.00 h) for 62.1 +/- 1.4 days (mean +/- SEM, n = 5) prepartum (14 August to 15 October). The remaining nine goats were kept under a natural photoperiod: 20 kids from these mothers were followed, five males and five females from each group. Testicular development was assessed by means of weekly measurement of scrotal circumference. Blood samples were taken once a week from all kids from 4 weeks of age for 5 months. Plasma was assayed for progesterone in females and testosterone in males. Autumn-born female kids initiated oestrous cyclicity in January, at a mean age of 12.8 +/- 0.8 weeks. Puberty onset was significantly delayed (P less than 0.03, unpaired Student's t test) in females exposed to 20 h light:4 h dark in utero and occurred at a mean age of 16.5 +/- 1.4 weeks. Testicular development was significantly delayed and plasma testosterone concentrations were lower in autumn-born male kids that experienced 20 h light:4 h dark in utero than in kids from mothers in a natural photoperiod.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Ritmo Circadiano , Cabras/fisiología , Luz , Maduración Sexual , Análisis de Varianza , Animales , Estro , Femenino , Masculino , Progesterona/sangre , Escroto/anatomía & histología , Estaciones del Año , Testículo/crecimiento & desarrollo , Testosterona/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA